BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Kevin K. Lin; Maria I. Harrell; Amit M. Oza; Ana Oaknin; Isabelle Ray-Coquard; Anna V. Tinker; Elena Helman; Marc R. Radke; Carmen Say; Lan-Thanh Vo

doi:10.1158/2159-8290.cd-18-0715

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Identifier:nobleid.org/w1/20260526/6D259DDF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6D259DDF.svg?ark=w1%2F20260526%2F6D259DDF)](https://nobleid.org/work/w1/20260526/6D259DDF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Identifier:nobleid.org/w1/20260526/6D259DDF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/6D259DDF.svg?ark=w1%2F20260526%2F6D259DDF)](https://nobleid.org/work/w1/20260526/6D259DDF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work